Pharmakotherapie in der Schwangerschaft
Authors:
- 22 March 2009
- journal article
- Published by Springer Nature in Die Innere Medizin
- Vol. 50 (4) , 455-466
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration DatabaseThe Journal of Rheumatology, 2009
- Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st centuryBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- Vitamin K antagonists and pregnancy outcomeThrombosis and Haemostasis, 2006
- Is erythromycin therapy teratogenic in humans?Reproductive Toxicology, 2005
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn NeurobehaviorPediatrics, 2004
- Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control groupArthritis & Rheumatism, 2003
- Cyclophosphamide, methotrexate, and cytarabine embropathy: Is apoptosis the common pathway?Birth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Teratogen update: Fetal effects after in utero exposure to coumarins Overview of cases, follow‐up findings, and pathogenesisTeratology, 2002
- Teratogen update: Azathioprine and 6‐mercaptopurineTeratology, 2002